Table 2.
Volumetric and clinical comparisons between groups—mean (SD) values expressed.
| Test | Controls (n = 32) | EOD (n = 16) | LOD (n = 14) | F ratio | P-value** | ||
|---|---|---|---|---|---|---|---|
| Mean ± SD* | Mean ± SD* | Mean ± SD* | Con vs. LOD | LOD vs. EOD | EOD vs. Con | ||
| Gray matter volume | 0.368 ± 0.005 | 0.373 ± 0.008 | 0.366 ± 0.009 | 1.68 | 0.565 | 0.364 | 0.568 |
| White matter volume | 0.338 ± 0.006 | 0.363 ± 0.009 | 0.363 ± 0.010 | 4.60 | 0.070 | 0.731 | 0.044 |
| MWT | 31.53 ± 2.58 | 29.37 ± 3.42 | 31.07 ± 2.84 | 3.05 | 0.883 | 0.280 | 0.057 |
| CVLTIs | 60.75 ± 1.44 | 58.05 ± 2.19 | 50.67 ± 2.44 | 6.20 | 0.001 | 0.042 | 0.460 |
| CVLTvfw1 | 13.14 ± 0.42 | 12.43 ± 0.63 | 9.84 ± 0.71 | 7.85 | <0.001 | 0.014 | 0.728 |
| CVLTvfw2 | 13.56 ± 0.44 | 13.33 ± 0.66 | 10.69 ± 0.74 | 5.42 | 0.002 | 0.017 | 0.986 |
| TMT A | 27.16 ± 7.78 | 35.69 ± 12.98 | 38.14 ± 12.95 | 6.79 | 0.007 | 0.819 | 0.035 |
| TMT B | 56.65 ± 17.41 | 72.63 ± 28.89 | 86.64 ± 38.00 | 6.97 | 0.003 | 0.349 | 0.135 |
| TMT total | 83.75 ± 22.50 | 108.31 ± 39.28 | 119.07 ± 55.25 | 5.58 | 0.013 | 0.723 | 0.090 |
| BDI II | 2.48 ± 1.31 | 13.26 ± 2.08 | 7.76 ± 2.24 | 10.6 | 0.051 | 0.103 | 0.001 |
| BRMAS | 0.49 ± 0.27 | 1.17 ± 0.41 | 0.41 ± 0.46 | 1.044 | 0.890 | 0.258 | 0.687 |
| SCL 90 | 0.20 ± 0.07 | 0.74 ± 0.11 | 0.469 ± 0.12 | 9.29 | 0.065 | 0.13 | 0.000 |
| STAI_G | 34.12 ± 2.16 | 35.38 ± 3.00 | 34.69 ± 3.40 | 2.782 | 0.891 | 0.89 | 0.116 |
CVLT, California Verbal Learning Task CVLTIs; BDI II, Beck depression Inventory; BRMAS, Bech Rafaelsen Mania Scale; MWT, Mehrfachwahl-Wortschatz-Test; SCL90, STAI-G: State-Trait Anxiety Inventory; SCL 90, Symptom checklist 90 items; EOD, Early Onset of Disease (< 27 years); LOD, Late Onset of Disease (≥27 years)
Estimate Mean.
P = significant on a ≤ 0.05-threshold. Values are highlighted in bold to show significant comparisons at p < 0.05 threshold.